Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: Cohort study with nested case-control

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2927-2933

  Marwick, Charis A ^a   Yu, Ning ^a   Lockhart, Michael C ^b   McGuigan, Christopher C ^c   Wiuff, Camilla ^d   Davey, Peter G ^a   Donnan, Peter T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c King's Cross Hospital   (United Kingdom)

^d HEALTH PROTECTION SCOTLAND   (United Kingdom)

Author keywords

Antimicrobials; Community acquired infections; Elderly; Long term care facilities; Nursing homes; Proton pump inhibitors

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; QUINOLONE DERIVATIVE;

AGED; ARTICLE; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMMUNITY ASSOCIATED CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PROSPECTIVE STUDY; UNITED KINGDOM;

ANTIMICROBIALS; COMMUNITY-ACQUIRED INFECTIONS; ELDERLY; LONG-TERM CARE FACILITIES; NURSING HOMES; PROTON PUMP INHIBITORS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; NURSING HOMES; PROSPECTIVE STUDIES; RISK ASSESSMENT; SCOTLAND;

EID: 84887008394     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt257     Document Type: Article

References (28)

1. Health Protection Scotland. Quarterly Report on the Surveillance of Clostridium difficile Associated Disease (CDAD) in Scotland, January 2009-March 2009 http://www.hps.scot.nhs.uk/haiic/sshaip/wrdetail. aspx?id=41927&wrtype=6 (17 September 2009, date last accessed).
2. Morbidity & Mortality Weekly Report. Surveillance for communityassociated Clostridium difficile-Connecticut, 2006. MMWR 2008; 57: 340-3.
3. Dial S, Delaney JA, BarkunANet al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294: 2989-95.
4. Khanna S, Pardi DS, Aronson SL et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012; 107: 89-95.
5. Kuntz JL, Chrischilles EA, Pendergast JF et al. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 2011; 11: 194.
6. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficileassociated disease in North America and Europe. Clin Microbiol Infect 2006; 12 Suppl 6: 2-18.
7. DialSMDM,KezouhAP, DascalAMDet al. Patterns of antibioticuseandrisk of hospital admission because of Clostridium difficile infection. Can Med Assoc J 2008; 179: 767-72.
8. Delaney JA, Dial S, Barkun A et al. Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis 2007; 13: 761-3.
9. Dial S, Delaney JA, Schneider V et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. Can Med Assoc J 2006; 175: 745-8.
10. Wilcox MH, Mooney L, Bendall R et al. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62: 388-96.
11. Dumyati G, Stevens V, Hannett GE et al. Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis 2012; 18: 392-400.
12. Beaugerie L, Flahault A, Barbut F et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharm Ther 2003; 17: 905-12.
13. Hirschhorn LR, Trnka Y, Onderdonk A et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994; 169: 127-33.
14. Hensgens MPM, Goorhuis A, DekkersOMet al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012; 67: 742-8.
15. Kutty PK, Woods CW, Sena AC et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010; 16: 197-204.
16. Stevens V,Dumyati G, Fine LS et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011; 53: 42-8.
17. Arvand M, Moser V, Schwehn C et al. High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PloS One 2012; 7: e30183.
18. Verspui-van der Eijk PA, Hensgens MP, de Jong J et al. Emerging outbreaks of Clostridium difficile in regional long-term care facilities. Clin Microbiol Infect 2012; 18: 111.
19. Kim JH, Toy D, Muder RR. Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term careassociated illness. Infect Control Hosp Epidemiol 2011; 32: 656-60.
20. Deshpande A, Pant C, Pasupuleti V et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a metaanalysis. Clin Gastroenterol Hepatol 2012; 10: 225-33.
21. Janarthanan S, Ditah I, Adler DG et al. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107: 1001-10.
22. Kwok CS, Arthur AK, Anibueze CI et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107: 1011-9.
23. HM Government UK. Public Services Reform (Scotland) Act 2010, Schedule 12. http://www.legislation.gov.uk/asp/2010/8/schedule/12/ paragraph/2 (10 December 2012, date last accessed).
24. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
25. Perkins AJ, Kroenke K, Unutzer J et al. Commoncomorbidity scaleswere similar in their ability to predict health care costs and mortality. J Clin Epidemiol 2004; 57: 1040-8.
26. Information Services Division Scotland. Scottish Index of Multiple Deprivation. http://www.scotland.gov.uk/Topics/Statistics/SIMD (14 June 2011, date last accessed).
27. University of Dundee. Health Informatics Centre. http://medicine. dundee.ac.uk/health-informatics-centre (22 November 2012, date last accessed).
28. Scallan E, Fitzgerald M, Cormican M et al. The investigation of acute gastroenteritis in general practice: a survey of general practitioners in Northern Ireland and Republic of Ireland. Eur J Gen Pract 2005; 11: 136-8.